| Dr John J Giustozzi, MD | |
|
100 E Carroll St, Salisbury, MD 21801-5422 | |
| (410) 543-7375 | |
| Not Available |
| Full Name | Dr John J Giustozzi |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 100 E Carroll St, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194706622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0051935 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nittany Anesthesia Pc | 9931196318 | 5 |
News Archive
The best way to prevent a fracture is to stop bones from reaching the point where they are prone to breaking, but understanding the process of how bones form and mature has been challenging. Now researchers at the University of Houston department of health and human performance have created a process that grows real human bone in tissue culture, which can be used to investigate how bones form and grow.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.Scientists have identified a way to target and destroy Glioblastoma multiforme (GBM) cells without harming healthy cells.
› Verified 1 days ago
| Entity Name | Nittany Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528102712 PECOS PAC ID: 9931196318 Enrollment ID: O20040428000236 |
News Archive
The best way to prevent a fracture is to stop bones from reaching the point where they are prone to breaking, but understanding the process of how bones form and mature has been challenging. Now researchers at the University of Houston department of health and human performance have created a process that grows real human bone in tissue culture, which can be used to investigate how bones form and grow.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.Scientists have identified a way to target and destroy Glioblastoma multiforme (GBM) cells without harming healthy cells.
› Verified 1 days ago
| Entity Name | Remcare Anesthesia Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396923835 PECOS PAC ID: 1052496833 Enrollment ID: O20080305000026 |
News Archive
The best way to prevent a fracture is to stop bones from reaching the point where they are prone to breaking, but understanding the process of how bones form and mature has been challenging. Now researchers at the University of Houston department of health and human performance have created a process that grows real human bone in tissue culture, which can be used to investigate how bones form and grow.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.Scientists have identified a way to target and destroy Glioblastoma multiforme (GBM) cells without harming healthy cells.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J Giustozzi, MD 1325 Mount Hermon Rd, Suite 14b, Salisbury, MD 21804-5259 Ph: (410) 742-4401 | Dr John J Giustozzi, MD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (410) 543-7375 |
News Archive
The best way to prevent a fracture is to stop bones from reaching the point where they are prone to breaking, but understanding the process of how bones form and mature has been challenging. Now researchers at the University of Houston department of health and human performance have created a process that grows real human bone in tissue culture, which can be used to investigate how bones form and grow.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.Scientists have identified a way to target and destroy Glioblastoma multiforme (GBM) cells without harming healthy cells.
› Verified 1 days ago
Alex L Mah, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-543-7375 | |
Dr. David M. Schalk, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 804 Snow Hill Rd, Salisbury, MD 21804 Phone: 410-546-0300 Fax: 410-546-8364 | |
Nicholas A Woodford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 East Carroll Street, Salisbury, MD 21801 Phone: 410-543-7375 | |
Dr. Ben Tacheron, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6503 Deer Pointe Dr Ste A, Salisbury, MD 21804 Phone: 855-527-7246 Fax: 866-229-5063 | |
Dr. Supriya Banad Jagannath, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-543-7375 | |
Dr. Conworth L Dayton-jones, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 264 Tilghman Rd, Salisbury, MD 21804 Phone: 410-742-7246 |